A new study in Science challenges long-held theories of why a common virus—cytomegalovirus, or CMV—can reactivate and become a life-threatening infection in people with a compromised immune system, including blood cancer ...
Jan 17, 2019
0
124
(HealthDay)—A stem cell transplant may help some people with multiple sclerosis (MS) when standard drugs fail, a new clinical trial finds.
Jan 15, 2019
0
44
UCLA researchers led by Dr. Donald Kohn have created a method for modifying blood stem cells to reverse the genetic mutation that causes a life-threatening autoimmune syndrome called IPEX. The gene therapy, which was tested ...
Jan 11, 2019
0
400
Bone marrow transplants, which involve transplanting healthy blood stem cells, offer the best treatment for many types of cancers, blood disorders and immune diseases. Even though 22,000 of these procedures are performed ...
Jan 9, 2019
0
6
Umbilical cord blood stem cells that are cultured and expanded outside the body before being used for bone marrow transplant in adult blood cancer patients appear safe and restore blood count recovery faster than standard ...
Dec 4, 2018
0
0
Improving outcomes for patients with myeloid cancers who undergo stem cell transplantation is a focus of several studies to be presented by Dana-Farber Cancer Institute scientists at the American Society of Hematology (ASH) ...
Dec 4, 2018
0
1
Researchers at Memorial Sloan Kettering Cancer Center (MSK) reported results from a new study that looks at the likelihood of complications for people undergoing bone marrow transplants (BMTs). The observational study found ...
Dec 3, 2018
0
2
Stem cell transplantation is effective against leukemia. In many cases, however, the transferred immune cells of the donor also attack the recipients' healthy tissue—often with fatal consequences. Researchers at the University ...
Nov 29, 2018
0
396
The U.S. Food and Drug Administration (FDA) has approved the first ever inhibitor drug specifically approved for treating patients with relapsed or refractory acute myeloid leukemia (AML) with a mutation in the Fms-like tyrosine ...
Nov 28, 2018
0
5
Clinical trial results published in the journal Nature Medicine show 91 percent response rate to the combination of venetoclax with azacitidine in older adults newly diagnosed with acute myeloid leukemia (AML). Of 33 patients ...
Nov 28, 2018
0
72
